Researchers developed TETRIS, a technology that maps out diverse protein interactions in cells using DNA barcodes, capturing higher-order interactions linked to aggressive cancers. This enables precise diagnostics and tailored therapies.
Researchers found that Brusatol increases Gem's effectiveness against pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling. The study also showed that combining Brusatol with Nrf2 silencing significantly enhanced Gem's efficacy in vitro and in vivo.
The American Academy of Pediatrics recommends pediatricians support families with guidance and books at well-child visits. Shared reading strengthens bonds and stimulates brain circuitry, creating early attachments. This practice has enduring benefits for social-emotional, cognitive, language, and literacy development.
Researchers found that At2-MMP is essential for suppressing abnormal cell division and preventing excessive proliferation in wounded Arabidopsis stems. Overexpression of At2-MMP restored normal wound healing processes.
A phase II clinical trial found that radiopharmaceuticals, specifically 177Lu-Dotatate, can extend progression-free survival for patients with refractory meningioma by nearly 80% after six months. The therapy offers a safe and effective treatment option for those with aggressive tumor growth.
Huaier has been traditionally used to treat various health conditions, including cancer. Its unique chemical composition and molecular mechanisms of action have shown potent antitumor effects in both in-vitro and in-vivo studies. Further research is needed to fully understand its efficacy and safety in cancer therapy.
A new study by Tel Aviv University reveals that 27% of respondents withhold inventions due to reasons such as emotional attachment, fear of credit, or lack of trust in management. The study aims to shed light on this phenomenon and develop effective management tools to increase employees' willingness to disclose their inventions.
The study challenges the idea of creating artificial general intelligence (AGI) with human-level cognition, citing limitations in replicating human cognition. Researchers argue that even under ideal circumstances, it is impossible to achieve AGI due to the complexity of cognitive processes.
A study found that naldemedine reduces constipation in cancer patients taking opioids, improving quality of life and reducing nausea. After 14 days, 64.6% of naldemedine-treated patients showed no signs of constipation compared to 17.0% in the placebo group.
A new method combines confocal fluorescence microscopy with microfluidic laminar flow to detect nanoparticles and viruses quickly and accurately. The approach uses a 3D-printed Brick-MIC setup for sensitivity and specificity improvements, potentially changing virus detection in clinical settings.
Researchers at KAUST have developed a new cooling system that extracts water from the air using gravity, eliminating the need for electricity. The system can double the rate of water collection compared to alternative technologies and offers significant energy savings.
The study finds that chemokines, particularly CXCL12/CXCR4 axis, are upregulated in patients with atrial fibrillation, contributing to increased remodeling and risk of death. Elevated expression of CXCR2 is also linked to monocyte infiltration and accelerated atrial remodeling.
Scientists have created extremely thin sheets of nitrogen-vacancy (NV) centers in diamond crystals, which exhibit exceptional sensitivity to environmental variations. The findings reveal the emergence of Fröhlich polarons, previously thought not to exist in diamonds, opening up new prospects for quantum sensing.
A Duke-NUS study proposes a new treatment for heart failure with preserved ejection fraction (HFpEF) by blocking glucagon's activity, which raises blood sugar levels. This breakthrough could provide quicker relief to millions of heart patients.
A pooled analysis of three large, phase III clinical trials found that more than 40% of brain metastases patients can fully reverse cognitive losses with conformal radiation techniques. Recovery was more likely for those treated with highly targeted radiation compared to standard whole-brain treatment.
Researchers have developed four advanced technologies to break down PFAS compounds, including hydrothermal alkali treatment, low-temperature mineralization, mechanochemical degradation, and adsorption. These methods demonstrate high efficiency in addressing the widespread environmental and health risks associated with PFAS.